Clinical Trial Update: A Study of V503 Given Concomitantly With Menactra™ and Adacel™ in 11 to 15 Year Olds (V503-005) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for V503 in adolescents; results completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Drugs mentioned

• V503

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Human Papillomavirus Infection | Phase 3 | Status: COMPLETED | Results posted: 2015-01-13